Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 6Biliary Tract Neoplasms 5Rectal Neoplasms 3Colonic Neoplasms 3Gastrointestinal Stromal Tumors 2Carcinoma, Hepatocellular 2Stomach Neoplasms 1Piebaldism 1Pancreatic Neoplasms 1Locally Advanced Rectal Carcinoma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Advanced Pancreatic Cancer 1

Interventions

Oxaliplatin 271Fluorouracil 268Capecitabine 235Leucovorin 209Irinotecan 152Radiotherapy 139Bevacizumab 114Cetuximab 82Surgical Procedures, Operative 51Folfox protocol 49Neoadjuvant Therapy 45Drug Therapy 43Radiation 42Chemotherapy, Adjuvant 34Chemoradiotherapy 34Panitumumab 27Magnetic Resonance Spectroscopy 26XELOX 25Radiotherapy, Intensity-Modulated 23Biopsy 20Surveys and Questionnaires 18Laparoscopy 18Proctectomy 17Floxuridine 17Early Intervention, Educational 16Nivolumab 15Immunohistochemistry 15Gene Expression Profiling 15Gemcitabine 15pembrolizumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Rectal Neoplasms × envafolimab × Gastrointestinal × Clear all
NCT05969847 2023-08-01

TRACE-LE

Fujian Medical University Union Hospital

Phase 2 Not yet recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05858567 2023-05-15

RECMULRA-TNT

Sir Run Run Shaw Hospital

Phase 2 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05752136 2023-05-08

Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma

Sir Run Run Shaw Hospital

Phase 3 Recruiting
108 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡